Webinar

FDA: Embracing Flexibility at the Agency for Advancing Innovative Therapies

In this fireside chat, “FDA: Embracing Flexibility at the Agency for Advancing Innovative Therapies,” our experts discuss the evolving landscape of regulatory frameworks at the FDA and how flexibility is crucial for the advancement of cell and gene therapies. They share insights on the importance of engaging with various stakeholders and the role of adaptive strategies in navigating the regulatory environment to bring innovative therapies to market. 

Explore how embracing flexibility and fostering collaboration with regulatory bodies can enhance the development and approval processes for innovative therapies, ultimately benefiting patients in need.

Speakers: 

  • Louis Cicchini - Director, Scientific Affairs, Cell & Gene Therapy at Cencora 
  • Celia Witten - Principal at Eliquent Life Sciences 

Fill out the form to watch the session

Pardot Form

Connect with our cell and gene therapy team

Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you.

Related resources

Article

Harnessing AI and advanced analytics to revolutionize PV signal management
Learn more

Webinar

Navigating global policy shifts: Implications for Europe's pharma landscape
Learn more

Article

The growing case for AI to support pharmacovigilance: World Drug Safety Congress Americas key takeaways
Learn more